Fortress Biotech Inc - Company Profile
Powered by
All the data and insights you need on Fortress Biotech Inc in one report.
- Save hours of research time and resources with
our up-to-date Fortress Biotech Inc Strategy Report
- Understand Fortress Biotech Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Fortress Biotech Inc (Fortress Biotech), formerly Coronado Biosciences Inc, identifies, acquires, develops and commercializes marketed pharmaceuticals and development-stage pharmaceutical product candidates. The company provides business, scientific, regulatory, and legal support for advancing the products or product candidates of its partner firms. It is a marketing partner for various branded drugs indicated for the treatment of radiation dermatitis, severe acne, athlete’s foot, inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and other skin infections. Fortress Biotech is headquartered in Florida, the US.
Fortress Biotech Inc premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Marketed | In-Licensing Services | Qbrexza |
Exelderm | Drug Development Services | Accutane |
Ximino | Amzeeq | |
XYZ | XYZ | |
XYZ | XYZ | |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In May, the company and uBriGene (Boston) Biosciences entered into a strategic manufacturing partnership to support MB-106 and future pipeline. |
2023 | Contracts/Agreements | In April, Aevitas Therapeutics signed an asset purchase agreement with 4D Molecular Therapeutics for the treatment of complement-mediated diseases. |
2022 | Contracts/Agreements | In December, Urica Therapeutics, Inc. expanded its license agreement with Fuji Yakuhin Co. Ltd. for the development of dotinurad to include the Middle East and North Africa and Turkey territories. |
Competitor Comparison
Key Parameters | Fortress Biotech Inc | Sun Pharmaceutical Industries Ltd | Almirall SA | Mayne Pharma Group Ltd | Galderma Laboratories LP |
---|---|---|---|---|---|
Headquarters | United States of America | India | Spain | Australia | United States of America |
City | Bay Harbor Islands | Mumbai | Barcelona | Adelaide | Fort Worth |
State/Province | Florida | Maharashtra | - | South Australia | Texas |
No. of Employees | 186 | 41,000 | 1,904 | 900 | - |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Lindsay A. Rosenwald | Chairman; Chief Executive Officer; President | Executive Board | 2013 | 67 |
Michael S. Weiss | Executive Vice Chairman, Strategic Development | Executive Board | 2014 | 56 |
Robyn M. Hunter | Chief Financial Officer | Senior Management | 2017 | 60 |
David Jin | Head - Corporate Development; Chief Financial Officer | Senior Management | 2022 | 32 |
Eric K. Rowinsky | Vice Chairman | Executive Board | 2010 | 66 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer